September 16, 2021

Two-Drug Therapy Authorized for COVID-19 Post-Exposure Prevention

Read More
September 16, 2021

Brukinsa Receives Two New Lymphoma Indications

Read More
September 16, 2021

Pfizer Expands Chantix Recall to Include all 0.5mg and 1mg Tablets

Read More
September 13, 2021

Three Lots of Ruzurgi Recalled Due to Contamination

Read More
September 8, 2021

One Lot of Firvanq Recalled After Being Packaged with Wrong Diluent

Read More
September 7, 2021

ICU Medical Recalls Aminosyn II Because of Particulate Matter

Read More
September 2, 2021

Pfizer Adds Four Lots to Chantix Recall

Read More
September 2, 2021

Drizalma Sprinkle Receives New Indication for Fibromyalgia

Read More
September 2, 2021

Opdivo Loses Indication as Single-Agent Treatment for Liver Cancer

Read More
September 1, 2021

FDA Approves New Long-Acting Schizophrenia Treatment

Read More
September 1, 2021

FDA Requires New Warnings on Drugs in the JAK Inhibitors Class

Read More
September 1, 2021

Brand Medications with Generic Alternatives Anticipated to be Approved in October

Read More